Received Oct 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
hallucinations with 24 hours of having the vaccine; This serious case was reported by a other health professional via sales rep and described the occurrence of hallucination in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, 24 hrs after receiving Shingrix, the patient experienced hallucination (Verbatim: hallucinations with 24 hours of having the vaccine) (serious criteria GSK medically significant). The outcome of the hallucination was not reported. It was unknown if the reporter considered the hallucination to be related to Shingrix. The company considered the hallucination to be unrelated to Shingrix. Additional Information: GSK Receipt Date: 27-SEP-2025 The patient experienced hallucinations within 24 hours of receiving a vaccine at a pharmacy. This side effect was not listed in the prescribing information; Sender's Comments: A case of Hallucination,, 24 hrs after receiving Shingrix, in a patient. Based on the available information, a possible causality that the event was caused by the GSK product cannot be ascertained. Further follow up information has been sought.